Pharmaceuticals & Biotech Mexican Community
Our community narratives are driven by numbers and valuation.
Pharmaceuticals & Biotech Mexican Investing Ideas
Productivity Savings And Channel Expansion Will Support A Stronger Long Term Earnings Profile
Catalysts About Genomma Lab Internacional. de Genomma Lab Internacional.Read more
0
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Mex$30
40.1% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
8.7% p.a.
Profit Margin
14.62%
Future PE
12.93x
Price in 2029
Mex$44.65
Seasonal Volatility And Cost Cuts Will Test Margin Ambitions Yet Support A Cautious Upside View
Catalysts About Genomma Lab Internacional. de Genomma Lab Internacional.Read more
2
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Mex$20
10.2% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
4% p.a.
Profit Margin
12.54%
Future PE
11.37x
Price in 2029
Mex$29.77
Productivity Program And E Commerce Expansion Will Drive Long Term Market Share Gains
Catalysts About Genomma Lab Internacional. de Genomma Lab Internacional.Read more
8
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Mex$26.8
33.0% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
6.13% p.a.
Profit Margin
13.83%
Future PE
12.95x
Price in 2028
Mex$39.99
